Robert Preti

New York Blood Center, Inc. operates blood distribution and research organizations. It provides blood and blood products for transfusions annually. The company was founded in 1964 and is located in New York, NY.

The American Association of Blood Banks is a professional organization dedicated to advancing the field of transfusion medicine and cellular therapies. The non-profit company is based in Bethesda, MD and has subsidiaries in Puerto Rico. The association provides accreditation and certification programs for blood banks and transfusion services, as well as educational resources and advocacy efforts.

Minaris Regenerative Medicine LLC provides cell therapy services. It provides contract development and manufacturing organization (CDMO) services at current Good Manufacturing Practices (cGMP) standards, including clinical manufacturing, commercial manufacturing, and manufacturing development. The company was founded by Robert A. Preti and Andrew L. Pecora in 1997 and is headquartered in Allendale, NJ.

RoosterBio, Inc. provides standardized stem cell platforms that enable clinical and commercial translation. Its products include bioprocess media, plug and play systems, clinical control, and roosterbio swag products. The company was founded Jon A. Rowley in 2013 and is headquartered in Frederick, MD.

Humco, Inc. operates hospitals and healthcare centers. Its services include total preparation, processing, and arrangement, transportation and specialized international insurance programs. The company is headquartered in Baltimore, MD.

International Society for Cellular Therapy conducts research, processing, and manipulation of cells. The private company is based in Vancouver, CA. The Canadian company publishes researched materials. and has subsidiaries in the United States.

Hackensack University Medical Center's standing as one of New Jersey's and the nation's healthcare leaders are driven by a commitment to quality. At the firm quality means always striving to deliver the best medicine to its patients. It means always re-evaluating the delivery of healthcare to ensure that high standards are achieved. It means never turning away from a community need, but instead redoubling its efforts and commitment to respond to those needs.

Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ.